In conclusion, our study demonstrates that ESP can effectively reduce IL-1β and IL-6 levels, suppress inflammation in RA, inhibit tumor-like proliferation of synovial cells, counteract NF-κB phosphorylation, and protect against joint damage in the RA model. Here, IL1B is linked to neoplasm.